-
1
-
-
4444230502
-
Smoking and Parkinson's disease: systematic review of prospective studies
-
Allam M.F., Campbell M.J., Hofman A., Del Castillo A.S., and Fernandez-Crehuet Navajas R. Smoking and Parkinson's disease: systematic review of prospective studies. Mov Disord 19 (2004) 614-621
-
(2004)
Mov Disord
, vol.19
, pp. 614-621
-
-
Allam, M.F.1
Campbell, M.J.2
Hofman, A.3
Del Castillo, A.S.4
Fernandez-Crehuet Navajas, R.5
-
2
-
-
14944348425
-
Increasing the intracellular availability of all-trans retinoic acid in neuroblastoma cells
-
Armstrong J.L., Ruiz M., Boddy A.V., Redfern C.P., Pearson A.D., and Veal G.J. Increasing the intracellular availability of all-trans retinoic acid in neuroblastoma cells. Br J Cancer 92 (2005) 696-704
-
(2005)
Br J Cancer
, vol.92
, pp. 696-704
-
-
Armstrong, J.L.1
Ruiz, M.2
Boddy, A.V.3
Redfern, C.P.4
Pearson, A.D.5
Veal, G.J.6
-
3
-
-
0033846277
-
Central nicotinic receptors, neurotrophic factors and neuroprotection
-
Belluardo N., Mudo G., Blum M., and Fuxe K. Central nicotinic receptors, neurotrophic factors and neuroprotection. Behav Brain Res 113 (2000) 21-34
-
(2000)
Behav Brain Res
, vol.113
, pp. 21-34
-
-
Belluardo, N.1
Mudo, G.2
Blum, M.3
Fuxe, K.4
-
4
-
-
0027987497
-
Metabolism of nicotine to cotinine studied by a dual stable isotope method
-
Benowitz N.L., and Jacob III P. Metabolism of nicotine to cotinine studied by a dual stable isotope method. Clin Pharmacol Ther 56 (1994) 483-493
-
(1994)
Clin Pharmacol Ther
, vol.56
, pp. 483-493
-
-
Benowitz, N.L.1
Jacob III, P.2
-
5
-
-
0037449118
-
The potential role of cotinine in the cognitive and neuroprotective actions of nicotine
-
Buccafusco J.J., and Terry Jr. A.V. The potential role of cotinine in the cognitive and neuroprotective actions of nicotine. Life Sci 72 (2003) 2931-2942
-
(2003)
Life Sci
, vol.72
, pp. 2931-2942
-
-
Buccafusco, J.J.1
Terry Jr., A.V.2
-
6
-
-
33846414011
-
Disconnection between activation and desensitization of autonomic nicotinic receptors by nicotine and cotinine
-
Buccafusco J.J., Shuster L.C., and Terry Jr. A.V. Disconnection between activation and desensitization of autonomic nicotinic receptors by nicotine and cotinine. Neurosci Lett 413 (2007) 68-71
-
(2007)
Neurosci Lett
, vol.413
, pp. 68-71
-
-
Buccafusco, J.J.1
Shuster, L.C.2
Terry Jr., A.V.3
-
7
-
-
0037713665
-
Inhibition of human MAO-A and MAO-B by a compound isolated from flue-cured tobacco leaves and its neuroprotective properties in the MPTP mouse model of neurodegeneration
-
Castagnoli K., Petzer J.B., Steyn S.J., van der Schyf C.J., and Castagnoli Jr. N. Inhibition of human MAO-A and MAO-B by a compound isolated from flue-cured tobacco leaves and its neuroprotective properties in the MPTP mouse model of neurodegeneration. Inflammopharmacology 11 (2003) 183-188
-
(2003)
Inflammopharmacology
, vol.11
, pp. 183-188
-
-
Castagnoli, K.1
Petzer, J.B.2
Steyn, S.J.3
van der Schyf, C.J.4
Castagnoli Jr., N.5
-
8
-
-
0035016740
-
Neuroprotection in the MPTP Parkinsonian C57BL/6 mouse model by a compound isolated from tobacco
-
Castagnoli K.P., Steyn S.J., Petzer J.P., Van der Schyf C.J., and Castagnoli Jr. N. Neuroprotection in the MPTP Parkinsonian C57BL/6 mouse model by a compound isolated from tobacco. Chem Res Toxicol 14 (2001) 523-527
-
(2001)
Chem Res Toxicol
, vol.14
, pp. 523-527
-
-
Castagnoli, K.P.1
Steyn, S.J.2
Petzer, J.P.3
Van der Schyf, C.J.4
Castagnoli Jr., N.5
-
9
-
-
33645929088
-
Neuroprotective effects of nicotine against salsolinol-induced cytotoxicity: implications for Parkinson's disease
-
Copeland Jr. R.L., Leggett Y.A., Kanaan Y.M., Taylor R.E., and Tizabi Y. Neuroprotective effects of nicotine against salsolinol-induced cytotoxicity: implications for Parkinson's disease. Neurotox Res 8 (2005) 289-293
-
(2005)
Neurotox Res
, vol.8
, pp. 289-293
-
-
Copeland Jr., R.L.1
Leggett, Y.A.2
Kanaan, Y.M.3
Taylor, R.E.4
Tizabi, Y.5
-
10
-
-
34548635103
-
Antiapoptotic effects of nicotine in its protection against salsolinol-induced cytotoxicity
-
Copeland Jr. R.L., Das J.R., Kanaan Y.M., Taylor R.E., and Tizabi Y. Antiapoptotic effects of nicotine in its protection against salsolinol-induced cytotoxicity. Neurotox Res 12 (2007) 61-69
-
(2007)
Neurotox Res
, vol.12
, pp. 61-69
-
-
Copeland Jr., R.L.1
Das, J.R.2
Kanaan, Y.M.3
Taylor, R.E.4
Tizabi, Y.5
-
11
-
-
0035847204
-
Nicotine prevents striatal dopamine loss produced by 6-hydroxydopamine lesion in the substantia nigra
-
Costa G., Abin-Carriquiry J.A., and Dajas F. Nicotine prevents striatal dopamine loss produced by 6-hydroxydopamine lesion in the substantia nigra. Brain Res 888 (2001) 336-342
-
(2001)
Brain Res
, vol.888
, pp. 336-342
-
-
Costa, G.1
Abin-Carriquiry, J.A.2
Dajas, F.3
-
12
-
-
12644314144
-
Brain monoamine oxidase A inhibition in cigarette smokers
-
Fowler J.S., Volkow N.D., Wang G.J., Pappas N., Logan J., Shea C., et al. Brain monoamine oxidase A inhibition in cigarette smokers. Proc Natl Acad Sci USA 93 (1996) 14065-14069
-
(1996)
Proc Natl Acad Sci USA
, vol.93
, pp. 14065-14069
-
-
Fowler, J.S.1
Volkow, N.D.2
Wang, G.J.3
Pappas, N.4
Logan, J.5
Shea, C.6
-
13
-
-
13344293709
-
Inhibition of monoamine oxidase B in the brains of smokers
-
Fowler J.S., Volkow N.D., Wang G.J., Pappas N., Logan J., MacGregor R., et al. Inhibition of monoamine oxidase B in the brains of smokers. Nature 379 (1996) 733-736
-
(1996)
Nature
, vol.379
, pp. 733-736
-
-
Fowler, J.S.1
Volkow, N.D.2
Wang, G.J.3
Pappas, N.4
Logan, J.5
MacGregor, R.6
-
15
-
-
0034214163
-
Human neuroblastoma SH-SY5Y cell line: neurosteroid-producing cell line relying on cytoskeletal organization
-
Guarneri P., Cascio C., Piccoli T., Piccoli F., and Guarneri R. Human neuroblastoma SH-SY5Y cell line: neurosteroid-producing cell line relying on cytoskeletal organization. J Neurosci Res 60 (2000) 656-665
-
(2000)
J Neurosci Res
, vol.60
, pp. 656-665
-
-
Guarneri, P.1
Cascio, C.2
Piccoli, T.3
Piccoli, F.4
Guarneri, R.5
-
16
-
-
0036714747
-
A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease
-
Hernan M.A., Takkouche B., Caamano-Isorna F., and Gestal-Otero JJ. A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease. Ann Neurol 52 (2002) 276-284
-
(2002)
Ann Neurol
, vol.52
, pp. 276-284
-
-
Hernan, M.A.1
Takkouche, B.2
Caamano-Isorna, F.3
Gestal-Otero JJ4
-
18
-
-
0023808881
-
Chronic nicotine treatment counteracts the disappearance of tyrosine-hydroxylase-immunoreactive nerve cell bodies, dendrites and terminals in the mesostriatal dopamine system of the male rat after partial hemitransection
-
Janson A.M., Fuxe K., Agnati L.F., Kitayama I., Harfstrand A., Andersson K., et al. Chronic nicotine treatment counteracts the disappearance of tyrosine-hydroxylase-immunoreactive nerve cell bodies, dendrites and terminals in the mesostriatal dopamine system of the male rat after partial hemitransection. Brain Res 455 (1988) 332-345
-
(1988)
Brain Res
, vol.455
, pp. 332-345
-
-
Janson, A.M.1
Fuxe, K.2
Agnati, L.F.3
Kitayama, I.4
Harfstrand, A.5
Andersson, K.6
-
19
-
-
0037185083
-
Stimulation of non-alpha7 nicotinic receptors partially protects dopaminergic neurons from 1-methyl-4-phenylpyridinium-induced toxicity in culture
-
Jeyarasasingam G., Tompkins L., and Quik M. Stimulation of non-alpha7 nicotinic receptors partially protects dopaminergic neurons from 1-methyl-4-phenylpyridinium-induced toxicity in culture. Neuroscience 109 (2002) 275-285
-
(2002)
Neuroscience
, vol.109
, pp. 275-285
-
-
Jeyarasasingam, G.1
Tompkins, L.2
Quik, M.3
-
20
-
-
0344616886
-
Neuroprotective effects of the novel D3/D2 receptor agonist and antiparkinson agent, S32504, in vitro against 1-methyl-4-phenylpyridinium (MPP+) and in vivo against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a comparison to ropinirole
-
Joyce J.N., Presgraves S., Renish L., Borwege S., Osredkar T., Hagner D., et al. Neuroprotective effects of the novel D3/D2 receptor agonist and antiparkinson agent, S32504, in vitro against 1-methyl-4-phenylpyridinium (MPP+) and in vivo against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a comparison to ropinirole. Exp Neurol 184 (2003) 393-407
-
(2003)
Exp Neurol
, vol.184
, pp. 393-407
-
-
Joyce, J.N.1
Presgraves, S.2
Renish, L.3
Borwege, S.4
Osredkar, T.5
Hagner, D.6
-
21
-
-
33645858566
-
Isolation and characterization of a monoamine oxidase B selective inhibitor from tobacco smoke
-
Khalil A.A., Davies B., and Castagnoli Jr. N. Isolation and characterization of a monoamine oxidase B selective inhibitor from tobacco smoke. Bioorg Med Chem 14 (2006) 3392-3398
-
(2006)
Bioorg Med Chem
, vol.14
, pp. 3392-3398
-
-
Khalil, A.A.1
Davies, B.2
Castagnoli Jr., N.3
-
22
-
-
34547189670
-
Parkin interacts with LIM kinase 1 and reduces its cofilin-phosphorylation activity via ubiquitination
-
Lim M.K., Kawamura T., Ohsawa Y., Ohtsubo M., Asakawa S., Takayanagi A., et al. Parkin interacts with LIM kinase 1 and reduces its cofilin-phosphorylation activity via ubiquitination. Exp Cell Res 313 (2007) 2858-2874
-
(2007)
Exp Cell Res
, vol.313
, pp. 2858-2874
-
-
Lim, M.K.1
Kawamura, T.2
Ohsawa, Y.3
Ohtsubo, M.4
Asakawa, S.5
Takayanagi, A.6
-
23
-
-
33846527409
-
Guidelines on nicotine dose selection for in vivo research
-
Matta S.G., Balfour D.J., Benowitz N.L., Boyd R.T., Buccafusco J.J., Caggiula A.R., et al. Guidelines on nicotine dose selection for in vivo research. Psychopharmacology (Berl) 190 (2007) 269-319
-
(2007)
Psychopharmacology (Berl)
, vol.190
, pp. 269-319
-
-
Matta, S.G.1
Balfour, D.J.2
Benowitz, N.L.3
Boyd, R.T.4
Buccafusco, J.J.5
Caggiula, A.R.6
-
24
-
-
7444233703
-
Inhibitory effects of cigarette smoke on glial inducible nitric oxide synthase and lack of protective properties against oxidative neurotoxins in vitro
-
Mazzio E.A., Kolta M.G., Reams R.R., and Soliman KFA. Inhibitory effects of cigarette smoke on glial inducible nitric oxide synthase and lack of protective properties against oxidative neurotoxins in vitro. Neurotoxicology 26 (2005) 49-62
-
(2005)
Neurotoxicology
, vol.26
, pp. 49-62
-
-
Mazzio, E.A.1
Kolta, M.G.2
Reams, R.R.3
Soliman KFA4
-
25
-
-
0029078869
-
Cigarette smoking and protection from Parkinson's disease: false association or etiologic clue?
-
Morens D.M., Grandinetti A., Reed D., White L.R., and Ross G.W. Cigarette smoking and protection from Parkinson's disease: false association or etiologic clue?. Neurology 45 (1995) 1041-1051
-
(1995)
Neurology
, vol.45
, pp. 1041-1051
-
-
Morens, D.M.1
Grandinetti, A.2
Reed, D.3
White, L.R.4
Ross, G.W.5
-
26
-
-
0011359002
-
The role of neuronal nicotinic acetylcholine receptors in acute and chronic neurodegeneration
-
O'Neill M.J., Murray T.K., Lakics V., Visanji N.P., and Duty S. The role of neuronal nicotinic acetylcholine receptors in acute and chronic neurodegeneration. Curr Drug Target CNS Neurol Disord 1 (2002) 399-411
-
(2002)
Curr Drug Target CNS Neurol Disord
, vol.1
, pp. 399-411
-
-
O'Neill, M.J.1
Murray, T.K.2
Lakics, V.3
Visanji, N.P.4
Duty, S.5
-
27
-
-
0035793423
-
Nicotine, but not cotinine, partially protects dopaminergic neurons against MPTP-induced degeneration in mice
-
Parain K., Marchand V., Dumery B., and Hirsch E. Nicotine, but not cotinine, partially protects dopaminergic neurons against MPTP-induced degeneration in mice. Brain Res 890 (2001) 347-350
-
(2001)
Brain Res
, vol.890
, pp. 347-350
-
-
Parain, K.1
Marchand, V.2
Dumery, B.3
Hirsch, E.4
-
28
-
-
2442426175
-
Terminally differentiated SH-SY5Y cells provide a model system for studying neuroprotective effects of dopamine agonists
-
Presgraves S.P., Ahmed T., Borwege S., and Joyce J.N. Terminally differentiated SH-SY5Y cells provide a model system for studying neuroprotective effects of dopamine agonists. Neurotox Res 5 (2004) 579-598
-
(2004)
Neurotox Res
, vol.5
, pp. 579-598
-
-
Presgraves, S.P.1
Ahmed, T.2
Borwege, S.3
Joyce, J.N.4
-
29
-
-
5044238005
-
Involvement of dopamine D(2)/D(3) receptors and BDNF in the neuroprotective effects of S32504 and pramipexole against 1-methyl-4-phenylpyridinium in terminally differentiated SH-SY5Y cells
-
Presgraves S.P., Borwege S., Millan M.J., and Joyce J.N. Involvement of dopamine D(2)/D(3) receptors and BDNF in the neuroprotective effects of S32504 and pramipexole against 1-methyl-4-phenylpyridinium in terminally differentiated SH-SY5Y cells. Exp Neurol 190 (2004) 157-170
-
(2004)
Exp Neurol
, vol.190
, pp. 157-170
-
-
Presgraves, S.P.1
Borwege, S.2
Millan, M.J.3
Joyce, J.N.4
-
30
-
-
34247578066
-
Nicotine neuroprotection against nigrostriatal damage; importance of the animal model
-
Quik M., O'Neill M., and Perez X.A. Nicotine neuroprotection against nigrostriatal damage; importance of the animal model. Trends Pharmacol Sci 28 (2007) 229-235
-
(2007)
Trends Pharmacol Sci
, vol.28
, pp. 229-235
-
-
Quik, M.1
O'Neill, M.2
Perez, X.A.3
-
31
-
-
33646823452
-
Chronic oral nicotine normalizes dopaminergic function and synaptic plasticity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned primates
-
Quik M., Chen L., Parameswaran N., Xie X., Langston J.W., and McCallum S.E. Chronic oral nicotine normalizes dopaminergic function and synaptic plasticity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned primates. J Neurosci 26 (2006) 4681-4689
-
(2006)
J Neurosci
, vol.26
, pp. 4681-4689
-
-
Quik, M.1
Chen, L.2
Parameswaran, N.3
Xie, X.4
Langston, J.W.5
McCallum, S.E.6
-
32
-
-
33748159130
-
Chronic oral nicotine treatment protects against striatal degeneration in MPTP-treated primates
-
Quik M., Parameswaran N., McCallum S.E., Bordia T., Bao S., McCormack A., et al. Chronic oral nicotine treatment protects against striatal degeneration in MPTP-treated primates. J Neurochem 98 (2006) 1866-1875
-
(2006)
J Neurochem
, vol.98
, pp. 1866-1875
-
-
Quik, M.1
Parameswaran, N.2
McCallum, S.E.3
Bordia, T.4
Bao, S.5
McCormack, A.6
-
33
-
-
34447255185
-
Pooled analysis of tobacco use and risk of Parkinson disease
-
Ritz B., Ascherio A., Checkoway H., Marder K.S., Nelson L.M., Rocca W.A., et al. Pooled analysis of tobacco use and risk of Parkinson disease. Arch Neurol 64 (2007) 990-997
-
(2007)
Arch Neurol
, vol.64
, pp. 990-997
-
-
Ritz, B.1
Ascherio, A.2
Checkoway, H.3
Marder, K.S.4
Nelson, L.M.5
Rocca, W.A.6
-
34
-
-
33846475136
-
Smoke from traditional commercial, harm reduction and research brand cigarettes impairs oviductal functioning in hamsters (Mesocricetus auratus) in vitro
-
Riveles K., Tran V., Roza R., Kwan D., and Talbot P. Smoke from traditional commercial, harm reduction and research brand cigarettes impairs oviductal functioning in hamsters (Mesocricetus auratus) in vitro. Hum Reprod 22 (2007) 346-355
-
(2007)
Hum Reprod
, vol.22
, pp. 346-355
-
-
Riveles, K.1
Tran, V.2
Roza, R.3
Kwan, D.4
Talbot P5
-
35
-
-
0035036071
-
Dose-related neuroprotective effects of chronic nicotine in 6-hydroxydopamine treated rats, and loss of neuroprotection in alpha4 nicotinic receptor subunit knockout mice
-
Ryan R.E., Ross S.A., Drago J., and Loiacono RE. Dose-related neuroprotective effects of chronic nicotine in 6-hydroxydopamine treated rats, and loss of neuroprotection in alpha4 nicotinic receptor subunit knockout mice. Br J Pharmacol 132 (2001) 1650-1656
-
(2001)
Br J Pharmacol
, vol.132
, pp. 1650-1656
-
-
Ryan, R.E.1
Ross, S.A.2
Drago, J.3
Loiacono RE4
-
36
-
-
0036639946
-
Effects of (-)-nicotine and (-)-cotinine on 6-hydroxydopamine-induced oxidative stress and neurotoxicity: relevance for Parkinson's disease
-
Soto-Otero R., Mendez-Alvarez E., Hermida-Ameijeiras A., Lopez-Real A.M., and Labandeira-Garcia JL. Effects of (-)-nicotine and (-)-cotinine on 6-hydroxydopamine-induced oxidative stress and neurotoxicity: relevance for Parkinson's disease. Biochem Pharmacol 64 (2002) 125-135
-
(2002)
Biochem Pharmacol
, vol.64
, pp. 125-135
-
-
Soto-Otero, R.1
Mendez-Alvarez, E.2
Hermida-Ameijeiras, A.3
Lopez-Real, A.M.4
Labandeira-Garcia JL5
-
37
-
-
33947605407
-
Alpha-synuclein overexpression reduces gap junctional intercellular communication in dopaminergic neuroblastoma cells
-
Sung J.Y., Lee H.J., Jeong E.I., Oh Y., Park J., Kang K.S., et al. Alpha-synuclein overexpression reduces gap junctional intercellular communication in dopaminergic neuroblastoma cells. Neurosci Lett 416 (2007) 289-293
-
(2007)
Neurosci Lett
, vol.416
, pp. 289-293
-
-
Sung, J.Y.1
Lee, H.J.2
Jeong, E.I.3
Oh, Y.4
Park, J.5
Kang, K.S.6
-
38
-
-
30744457894
-
Cotinine, a neuroactive metabolite of nicotine: potential for treating disorders of impaired cognition
-
Terry Jr. A.V., Hernandez C.M., Hohnadel E.J., Bouchard K.P., and Buccafusco J.J. Cotinine, a neuroactive metabolite of nicotine: potential for treating disorders of impaired cognition. CNS Drug Rev 11 (2005) 229-252
-
(2005)
CNS Drug Rev
, vol.11
, pp. 229-252
-
-
Terry Jr., A.V.1
Hernandez, C.M.2
Hohnadel, E.J.3
Bouchard, K.P.4
Buccafusco, J.J.5
-
39
-
-
33947546011
-
Temporal relationship between cigarette smoking and risk of Parkinson disease
-
Thacker E.L., O'Reilly E.J., Weisskopf M.G., Chen H., Schwarzschild M.A., McCullough M.L., et al. Temporal relationship between cigarette smoking and risk of Parkinson disease. Neurology 68 (2007) 764-768
-
(2007)
Neurology
, vol.68
, pp. 764-768
-
-
Thacker, E.L.1
O'Reilly, E.J.2
Weisskopf, M.G.3
Chen, H.4
Schwarzschild, M.A.5
McCullough, M.L.6
-
40
-
-
27744599399
-
Nicotine blocks ethanol-induced apoptosis in primary cultures of rat cerebral cortical and cerebellar granule cells
-
Tizabi Y., Manaye K.F., and Taylor R.E. Nicotine blocks ethanol-induced apoptosis in primary cultures of rat cerebral cortical and cerebellar granule cells. Neurotox Res 7 (2005) 319-322
-
(2005)
Neurotox Res
, vol.7
, pp. 319-322
-
-
Tizabi, Y.1
Manaye, K.F.2
Taylor, R.E.3
-
41
-
-
33747360178
-
Nicotine, but neither the alpha4beta2 ligand RJR2403 nor an alpha7 nAChR subtype selective agonist, protects against a partial 6-hydroxydopamine lesion of the rat median forebrain bundle
-
Visanji N.P., O'Neill M.J., and Duty S. Nicotine, but neither the alpha4beta2 ligand RJR2403 nor an alpha7 nAChR subtype selective agonist, protects against a partial 6-hydroxydopamine lesion of the rat median forebrain bundle. Neuropharmacology 51 (2006) 506-516
-
(2006)
Neuropharmacology
, vol.51
, pp. 506-516
-
-
Visanji, N.P.1
O'Neill, M.J.2
Duty, S.3
|